+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Immunoassay Market - Global Forecast 2026-2032- Product Image
Immunoassay Market - Global Forecast 2026-2032- Product Image
Sale

Immunoassay Market - Global Forecast 2026-2032

  • Report

  • 197 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 4904903
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Immunoassay Market is projected to reach USD 32.61 Billion in 2026. It is expected to continue growing at a CAGR of 7.36%, reaching USD 49.98 Billion by 2032.

Immunoassay is a core analytical technology in modern diagnostics, using highly specific antigen-antibody binding to detect biomarkers in blood, serum, plasma, saliva, urine, and other specimen types. Established formats such as enzyme-linked immunosorbent assay (ELISA), chemiluminescent immunoassay, fluorescence immunoassay, radioimmunoassay, and lateral flow immunoassay support clinical testing across infectious disease, oncology, cardiology, endocrinology, allergy, toxicology, autoimmune disease, fertility, and therapeutic drug monitoring.

Demand is supported by measurable healthcare needs, including aging populations, chronic disease prevalence, antimicrobial resistance surveillance, prenatal screening, blood safety, and pandemic preparedness. The World Health Organization reports that noncommunicable diseases account for about 74% of global deaths, reinforcing the need for scalable biomarker testing. Immunoassay remains strategically important because it combines scalable throughput, clinical familiarity, automation compatibility, cost-efficient workflows, and rapid turnaround for centralized laboratories and decentralized point-of-care testing.

Transformative Shifts in the Immunoassay Landscape

The immunoassay landscape is shifting from standalone, manual workflows toward automated, connected, and multiplexed diagnostic ecosystems. Clinical laboratories are prioritizing high-throughput analyzers, standardized reagent platforms, quality controls, and interfaces with laboratory information systems to reduce variability, improve traceability, and support faster clinical decisions.

At the same time, point-of-care immunoassay adoption is expanding as health systems seek earlier detection outside central labs, especially in emergency departments, primary care, pharmacies, rural clinics, and outbreak settings. Regulatory scrutiny is also increasing, particularly under the EU In Vitro Diagnostic Regulation and FDA oversight of higher-risk diagnostics, making analytical validation, clinical performance evidence, risk management, usability, and post-market surveillance essential competitive differentiators.

Cumulative Impact of Artificial Intelligence on Immunoassay

Artificial intelligence is becoming an operational accelerator for immunoassay development and deployment. AI-enabled image analysis can improve interpretation of lateral flow and fluorescence results, while machine learning supports assay optimization by modeling antibody-antigen interactions, background noise, cross-reactivity risk, interference patterns, and calibration curve performance.

In laboratories, AI contributes to predictive maintenance, workload forecasting, reflex-testing rules, result verification, and anomaly detection in quality control data. Its strongest near-term value is not replacing immunoassay science but improving reproducibility, throughput, and clinical integration when paired with validated datasets, transparent governance, cybersecurity controls, human oversight, and regulatory-grade documentation.

Key Regional Insights for Immunoassay

Asia-Pacific is a dynamic immunoassay region because China, India, Japan, South Korea, Australia, and Southeast Asian economies combine large patient pools with expanding diagnostic infrastructure, rising chronic disease testing, and greater use of automated and point-of-care platforms. North America remains highly mature, supported by regulated innovation, hospital networks, reference laboratories, reimbursement pathways, public health testing capacity, and strong uptake of automated immunoassay platforms for infectious disease, endocrine, cardiac, oncology, and therapeutic monitoring applications.

Europe is shaped by advanced laboratory medicine, national screening programs, accreditation practices, and stricter In Vitro Diagnostic Regulation evidence requirements, which increase the importance of clinical validation and post-market performance monitoring. Latin America is improving immunoassay access through private laboratory chains, public screening initiatives, and infectious disease testing for conditions such as dengue, HIV, hepatitis, and respiratory infections. The Middle East is investing in hospital modernization, preventive screening, specialty diagnostics, and laboratory automation, while Africa’s opportunity is strongly linked to scalable point-of-care immunoassays for HIV, malaria, hepatitis, pregnancy, tuberculosis screening support, and outbreak response, where decentralized testing can close access gaps in underserved areas.

Key Group Insights for Immunoassay

ASEAN countries are expanding immunoassay use through infectious disease surveillance, maternal health programs, hospital laboratory upgrades, and rising private diagnostics demand across urban centers. The GCC is investing in high-acuity hospitals, laboratory automation, local health security capacity, and preventive screening aligned with national health transformation agendas. The European Union is increasingly evidence-driven under IVDR, favoring suppliers with robust clinical validation, traceability, quality management systems, and documented post-market surveillance.

BRICS markets offer scale and localization potential, particularly where public procurement, domestic manufacturing policies, technology transfer, and access-oriented pricing influence adoption. G7 markets lead in premium analyzer adoption, companion diagnostics, reimbursement standards, laboratory accreditation, and digital laboratory integration. NATO members’ broader emphasis on health security also supports immunoassay capacity for biodefense readiness, blood safety, outbreak preparedness, military medical services, and deployable diagnostics in emergency settings.

Key Country Insights for Immunoassay

The United States leads immunoassay commercialization through large reference laboratories, integrated hospital systems, established FDA pathways, and strong demand for oncology, cardiac, infectious disease, autoimmune, allergy, and endocrine testing. Canada emphasizes quality-assured diagnostics within publicly funded care, while Mexico and Brazil combine infectious disease testing needs, chronic disease screening, and expanding private laboratory networks. The United Kingdom, Germany, France, Italy, and Spain remain central to European immunoassay adoption, supported by established clinical guidelines, laboratory accreditation, universal or near-universal healthcare systems, and advanced infrastructure.

Russia maintains demand for essential diagnostics despite procurement complexity and supply chain constraints. China and India are major growth engines due to population scale, chronic disease burden, domestic manufacturing capacity, expanding hospital networks, and public health testing needs. Japan, Australia, and South Korea are advanced immunoassay markets where automation, high-quality reagents, aging demographics, precision diagnostics, and strong laboratory quality standards continue to drive adoption across centralized and decentralized testing environments.

Actionable Recommendations for Immunoassay Industry Leaders

Industry leaders should prioritize assay menus with clear clinical utility, including infectious disease, cardiac markers, thyroid function, fertility, oncology biomarkers, autoimmune testing, allergy diagnostics, inflammation markers, and therapeutic drug monitoring. Competitive advantage will come from proven sensitivity, specificity, reproducibility, lot-to-lot consistency, calibration stability, interference management, and seamless analyzer integration.

Organizations should also invest in regional regulatory readiness, IVDR transition planning, quality system maturity, cybersecurity for connected analyzers, and AI governance. Partnerships with hospitals, reference laboratories, public health agencies, academic centers, and local distributors can improve evidence generation, reimbursement access, user training, service uptime, and adoption in both mature and emerging immunoassay markets.

Research Methodology

This executive summary is based on a structured review of publicly available, authoritative sources, including regulatory agency guidance, clinical laboratory standards, World Health Organization resources, peer-reviewed literature, health system reports, public procurement information, and disclosures from established diagnostics manufacturers.

The analysis evaluates immunoassay technologies, clinical applications, regional healthcare drivers, country-level diagnostic infrastructure, regulatory conditions, laboratory automation trends, point-of-care testing adoption, and AI-enabled workflow integration. Insights were synthesized using evidence triangulation, prioritizing verifiable facts over unsupported claims and excluding speculative data that could not be linked to credible healthcare, diagnostics, regulatory, or laboratory medicine indicators.

Conclusion

Immunoassay will remain a foundational diagnostics category because it addresses high-volume clinical needs while adapting to automation, multiplexing, point-of-care testing, digital connectivity, and AI-enabled workflow support. The category’s long-term relevance is reinforced by chronic disease management, infectious disease surveillance, preventive screening, blood safety, therapeutic monitoring, and precision medicine.

The next phase of leadership will depend on validated performance, regulatory discipline, accessible pricing, resilient supply chains, and intelligent workflow integration. Organizations that combine scientific reliability with scalable manufacturing, strong quality systems, clinical evidence, and evidence-based commercialization will be best positioned to meet demand across global immunoassay markets.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Immunoassay Market, by Type
7.1. Introduction
7.2. Qualitative Immunoassays
7.3. Quantitative Immunoassays
8. Immunoassay Market, by Technology
8.1. Introduction
8.2. Enzyme Immunoassays
8.3. Enzyme-Linked Immunosorbent Assay
8.4. Fluorescent Immunoassay
8.5. Lateral Flow Assay
8.6. Radioimmunoassay
8.7. Western Blot
9. Immunoassay Market, by Instruments
9.1. Introduction
9.2. Analyzers & Kits
9.3. Biosensors
9.4. Microfluidic Devices
9.5. Microplates
9.6. PCR Devices
9.7. Reagents
9.7.1. Antibodies
9.7.2. Antigens
9.7.3. Blocking Reagents
9.7.4. Buffers & Standards
9.7.5. Enzymes
9.7.6. Substrates
9.8. Software & Services
10. Immunoassay Market, by Sample Types
10.1. Introduction
10.2. Blood Samples
10.3. Saliva Samples
10.4. Tissue Samples
10.5. Urine Samples
11. Immunoassay Market, by Detection Modes
11.1. Introduction
11.2. Chemiluminescent
11.3. Colorimetric
11.4. Fluorometric
11.5. Radioisotopic
12. Immunoassay Market, by Application Areas
12.1. Introduction
12.2. Allergy
12.3. Autoimmune Diseases
12.4. Cardiology
12.5. Endocrinology
12.6. Infectious Diseases
12.7. Oncology
12.8. Toxicology
12.8.1. Drug Screening
12.8.2. Environmental Testing
13. Immunoassay Market, by End Users
13.1. Introduction
13.2. Contract Research Organizations
13.3. Diagnostic Laboratories
13.4. Hospitals & Clinics
13.5. Pharmaceutical & Biotechnology Companies
13.6. Research Institutions
14. Immunoassay Market, by Deployment Types
14.1. Introduction
14.2. Laboratory Tests
14.3. Point-of-care Test
15. Immunoassay Market, by Region
15.1. Asia-Pacific
15.2. North America
15.3. Latin America
15.4. Europe
15.5. Middle East
15.6. Africa
16. Immunoassay Market, by Group
16.1. ASEAN
16.2. GCC
16.3. European Union
16.4. BRICS
16.5. G7
16.6. NATO
17. Immunoassay Market, by Country
17.1. United States
17.2. Germany
17.3. China
17.4. United Kingdom
17.5. India
17.6. Japan
17.7. Russia
17.8. Brazil
17.9. Canada
17.10. Italy
17.11. Mexico
17.12. France
17.13. Spain
17.14. Australia
17.15. South Korea
18. Competitive Landscape
18.1. Market Share Analysis, 2025
18.2. FPNV Positioning Matrix, 2025
18.3. Market Concentration Analysis, 2025
18.3.1. Concentration Ratio (CR)
18.3.2. Herfindahl Hirschman Index (HHI)
18.4. Recent Developments & Impact Analysis, 2025
18.5. Product Portfolio Analysis, 2025
18.6. Benchmarking Analysis, 2025
19. Company Profiles
19.1. Abbott Laboratories
19.2. Agilent Technologies Inc.
19.3. ANP Technologies, Inc.
19.4. Autobio Diagnostics Co., Ltd.
19.5. Becton, Dickinson and Company
19.6. Bio-Rad Laboratories, Inc.
19.7. Bio-Techne Corporation
19.8. bioMérieux S.A.
19.9. Biosurfit SA
19.10. Boditech Med Inc.
19.11. Danaher Corporation
19.12. Diasorin S.p.A.
19.13. Dynex Technologies, Inc.
19.14. Epitope Diagnostics Inc.
19.15. F. Hoffmann-La Roche Ltd.
19.16. Fapon Biotech Inc.
19.17. H.U. Group Holdings Inc.
19.18. J. Mitra & Co. Pvt. Ltd.
19.19. Kamiya Biomedical Company
19.20. Merck KGaA
19.21. MiCo BioMed, Inc.
19.22. NanoEntek
19.23. Nanomix, Inc.
19.24. OPKO Health, Inc.
19.25. Promega Corporation
19.26. QIAGEN N.V.
19.27. Quanterix Corporation
19.28. Randox Laboratories Ltd.
19.29. Shenzhen Micropoint Biotechnologies Co., Ltd.
19.30. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
19.31. Siemens Healthineers AG
19.32. Sysmex Corporation
19.33. Thermo Fisher Scientific Inc.
19.34. Tosoh Corporation
19.35. WAK-Chemie Medical GmbH
19.36. Zoetis Inc.
19.37. Zybio Inc.
List of Figures
FIGURE 1. GLOBAL IMMUNOASSAY MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL IMMUNOASSAY MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL IMMUNOASSAY MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL IMMUNOASSAY MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL IMMUNOASSAY MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL IMMUNOASSAY MARKET SIZE, BY TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL IMMUNOASSAY MARKET SIZE, BY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
FIGURE 9. GLOBAL IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2025 VS 2032 (%)
FIGURE 11. GLOBAL IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2025 VS 2032 (%)
FIGURE 13. GLOBAL IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2025 VS 2032 (%)
FIGURE 15. GLOBAL IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2025 VS 2032 (%)
FIGURE 17. GLOBAL IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL IMMUNOASSAY MARKET SIZE, BY END USERS, 2025 VS 2032 (%)
FIGURE 19. GLOBAL IMMUNOASSAY MARKET SIZE, BY END USERS, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2025 VS 2032 (%)
FIGURE 21. GLOBAL IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL IMMUNOASSAY MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 23. GLOBAL IMMUNOASSAY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. GLOBAL IMMUNOASSAY MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 25. GLOBAL IMMUNOASSAY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 26. GLOBAL IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 27. GLOBAL IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 28. GLOBAL IMMUNOASSAY MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 29. GLOBAL IMMUNOASSAY MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL IMMUNOASSAY MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL IMMUNOASSAY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL IMMUNOASSAY MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL QUALITATIVE IMMUNOASSAYS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL QUALITATIVE IMMUNOASSAYS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL QUALITATIVE IMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL QUANTITATIVE IMMUNOASSAYS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL QUANTITATIVE IMMUNOASSAYS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL QUANTITATIVE IMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL ENZYME IMMUNOASSAYS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL ENZYME IMMUNOASSAYS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL ENZYME IMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL FLUORESCENT IMMUNOASSAY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL FLUORESCENT IMMUNOASSAY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL FLUORESCENT IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL LATERAL FLOW ASSAY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL LATERAL FLOW ASSAY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL LATERAL FLOW ASSAY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL RADIOIMMUNOASSAY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL RADIOIMMUNOASSAY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL RADIOIMMUNOASSAY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL WESTERN BLOT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL WESTERN BLOT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL WESTERN BLOT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL ANALYZERS & KITS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL ANALYZERS & KITS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL ANALYZERS & KITS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL BIOSENSORS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL BIOSENSORS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL BIOSENSORS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL MICROFLUIDIC DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL MICROFLUIDIC DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL MICROFLUIDIC DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL MICROPLATES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL MICROPLATES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL MICROPLATES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL PCR DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL PCR DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL PCR DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL REAGENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL REAGENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL REAGENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL ANTIBODIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL ANTIBODIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL ANTIBODIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL ANTIGENS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL ANTIGENS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL ANTIGENS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL BLOCKING REAGENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL BLOCKING REAGENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL BLOCKING REAGENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL BUFFERS & STANDARDS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL BUFFERS & STANDARDS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL BUFFERS & STANDARDS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL ENZYMES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL ENZYMES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL ENZYMES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL SUBSTRATES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL SUBSTRATES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL SUBSTRATES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL SOFTWARE & SERVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL SOFTWARE & SERVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL SOFTWARE & SERVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL BLOOD SAMPLES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL BLOOD SAMPLES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL BLOOD SAMPLES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL SALIVA SAMPLES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL SALIVA SAMPLES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL SALIVA SAMPLES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL TISSUE SAMPLES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL TISSUE SAMPLES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL TISSUE SAMPLES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL URINE SAMPLES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL URINE SAMPLES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL URINE SAMPLES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL CHEMILUMINESCENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL CHEMILUMINESCENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL CHEMILUMINESCENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL COLORIMETRIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL COLORIMETRIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL COLORIMETRIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL FLUOROMETRIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL FLUOROMETRIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL FLUOROMETRIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL RADIOISOTOPIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL RADIOISOTOPIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL RADIOISOTOPIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2017-2032 (USD MILLION)
TABLE 96. GLOBAL ALLERGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 97. GLOBAL ALLERGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 98. GLOBAL ALLERGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 99. GLOBAL AUTOIMMUNE DISEASES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 100. GLOBAL AUTOIMMUNE DISEASES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 101. GLOBAL AUTOIMMUNE DISEASES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 102. GLOBAL CARDIOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 103. GLOBAL CARDIOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 104. GLOBAL CARDIOLOGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 105. GLOBAL ENDOCRINOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 106. GLOBAL ENDOCRINOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 107. GLOBAL ENDOCRINOLOGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 108. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 109. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 110. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 111. GLOBAL ONCOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 112. GLOBAL ONCOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 113. GLOBAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 114. GLOBAL TOXICOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 115. GLOBAL TOXICOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 116. GLOBAL TOXICOLOGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 117. GLOBAL DRUG SCREENING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 118. GLOBAL DRUG SCREENING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 119. GLOBAL DRUG SCREENING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 120. GLOBAL ENVIRONMENTAL TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 121. GLOBAL ENVIRONMENTAL TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 122. GLOBAL ENVIRONMENTAL TESTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 123. GLOBAL IMMUNOASSAY MARKET SIZE, BY END USERS, 2017-2032 (USD MILLION)
TABLE 124. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 125. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 126. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 127. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 128. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 129. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 130. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 131. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 132. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 133. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 134. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 135. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 136. GLOBAL RESEARCH INSTITUTIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 137. GLOBAL RESEARCH INSTITUTIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 138. GLOBAL RESEARCH INSTITUTIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 139. GLOBAL IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2017-2032 (USD MILLION)
TABLE 140. GLOBAL LABORATORY TESTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 141. GLOBAL LABORATORY TESTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 142. GLOBAL LABORATORY TESTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 143. GLOBAL POINT-OF-CARE TEST MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 144. GLOBAL POINT-OF-CARE TEST MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 145. GLOBAL POINT-OF-CARE TEST MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 146. GLOBAL IMMUNOASSAY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 147. ASIA-PACIFIC IMMUNOASSAY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 148. ASIA-PACIFIC IMMUNOASSAY MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 149. ASIA-PACIFIC IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 150. ASIA-PACIFIC IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 151. ASIA-PACIFIC IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 152. ASIA-PACIFIC IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2017-2032 (USD MILLION)
TABLE 153. ASIA-PACIFIC IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2017-2032 (USD MILLION)
TABLE 154. ASIA-PACIFIC IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2017-2032 (USD MILLION)
TABLE 155. ASIA-PACIFIC IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2017-2032 (USD MILLION)
TABLE 156. ASIA-PACIFIC IMMUNOASSAY MARKET SIZE, BY END USERS, 2017-2032 (USD MILLION)
TABLE 157. ASIA-PACIFIC IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2017-2032 (USD MILLION)
TABLE 158. NORTH AMERICA IMMUNOASSAY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 159. NORTH AMERICA IMMUNOASSAY MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 160. NORTH AMERICA IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 161. NORTH AMERICA IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 162. NORTH AMERICA IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 163. NORTH AMERICA IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2017-2032 (USD MILLION)
TABLE 164. NORTH AMERICA IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2017-2032 (USD MILLION)
TABLE 165. NORTH AMERICA IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2017-2032 (USD MILLION)
TABLE 166. NORTH AMERICA IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2017-2032 (USD MILLION)
TABLE 167. NORTH AMERICA IMMUNOASSAY MARKET SIZE, BY END USERS, 2017-2032 (USD MILLION)
TABLE 168. NORTH AMERICA IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2017-2032 (USD MILLION)
TABLE 169. LATIN AMERICA IMMUNOASSAY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 170. LATIN AMERICA IMMUNOASSAY MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 171. LATIN AMERICA IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 172. LATIN AMERICA IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 173. LATIN AMERICA IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 174. LATIN AMERICA IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2017-2032 (USD MILLION)
TABLE 175. LATIN AMERICA IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2017-2032 (USD MILLION)
TABLE 176. LATIN AMERICA IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2017-2032 (USD MILLION)
TABLE 177. LATIN AMERICA IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2017-2032 (USD MILLION)
TABLE 178. LATIN AMERICA IMMUNOASSAY MARKET SIZE, BY END USERS, 2017-2032 (USD MILLION)
TABLE 179. LATIN AMERICA IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2017-2032 (USD MILLION)
TABLE 180. EUROPE IMMUNOASSAY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 181. EUROPE IMMUNOASSAY MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 182. EUROPE IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 183. EUROPE IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 184. EUROPE IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 185. EUROPE IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2017-2032 (USD MILLION)
TABLE 186. EUROPE IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2017-2032 (USD MILLION)
TABLE 187. EUROPE IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2017-2032 (USD MILLION)
TABLE 188. EUROPE IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2017-2032 (USD MILLION)
TABLE 189. EUROPE IMMUNOASSAY MARKET SIZE, BY END USERS, 2017-2032 (USD MILLION)
TABLE 190. EUROPE IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2017-2032 (USD MILLION)
TABLE 191. MIDDLE EAST IMMUNOASSAY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 192. MIDDLE EAST IMMUNOASSAY MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 193. MIDDLE EAST IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 194. MIDDLE EAST IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 195. MIDDLE EAST IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 196. MIDDLE EAST IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2017-2032 (USD MILLION)
TABLE 197. MIDDLE EAST IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2017-2032 (USD MILLION)
TABLE 198. MIDDLE EAST IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2017-2032 (USD MILLION)
TABLE 199. MIDDLE EAST IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2017-2032 (USD MILLION)
TABLE 200. MIDDLE EAST IMMUNOASSAY MARKET SIZE, BY END USERS, 2017-2032 (USD MILLION)
TABLE 201. MIDDLE EAST IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2017-2032 (USD MILLION)
TABLE 202. AFRICA IMMUNOASSAY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 203. AFRICA IMMUNOASSAY MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 204. AFRICA IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 205. AFRICA IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 206. AFRICA IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 207. AFRICA IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2017-2032 (USD MILLION)
TABLE 208. AFRICA IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2017-2032 (USD MILLION)
TABLE 209. AFRICA IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2017-2032 (USD MILLION)
TABLE 210. AFRICA IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2017-2032 (USD MILLION)
TABLE 211. AFRICA IMMUNOASSAY MARKET SIZE, BY END USERS, 2017-2032 (USD MILLION)
TABLE 212. AFRICA IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2017-2032 (USD MILLION)
TABLE 213. GLOBAL IMMUNOASSAY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 214. ASEAN IMMUNOASSAY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 215. ASEAN IMMUNOASSAY MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 216. ASEAN IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 217. ASEAN IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 218. ASEAN IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 219. ASEAN IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2017-2032 (USD MILLION)
TABLE 220. ASEAN IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2017-2032 (USD MILLION)
TABLE 221. ASEAN IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2017-2032 (USD MILLION)
TABLE 222. ASEAN IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2017-2032 (USD MILLION)
TABLE 223. ASEAN IMMUNOASSAY MARKET SIZE, BY END USERS, 2017-2032 (USD MILLION)
TABLE 224. ASEAN IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2017-2032 (USD MILLION)
TABLE 225. GCC IMMUNOASSAY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 226. GCC IMMUNOASSAY MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 227. GCC IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 228. GCC IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 229. GCC IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 230. GCC IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2017-2032 (USD MILLION)
TABLE 231. GCC IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2017-2032 (USD MILLION)
TABLE 232. GCC IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2017-2032 (USD MILLION)
TABLE 233. GCC IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2017-2032 (USD MILLION)
TABLE 234. GCC IMMUNOASSAY MARKET SIZE, BY END USERS, 2017-2032 (USD MILLION)
TABLE 235. GCC IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2017-2032 (USD MILLION)
TABLE 236. EUROPEAN UNION IMMUNOASSAY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 237. EUROPEAN UNION IMMUNOASSAY MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 238. EUROPEAN UNION IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 239. EUROPEAN UNION IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 240. EUROPEAN UNION IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 241. EUROPEAN UNION IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2017-2032 (USD MILLION)
TABLE 242. EUROPEAN UNION IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2017-2032 (USD MILLION)
TABLE 243. EUROPEAN UNION IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2017-2032 (USD MILLION)
TABLE 244. EUROPEAN UNION IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2017-2032 (USD MILLION)
TABLE 245. EUROPEAN UNION IMMUNOASSAY MARKET SIZE, BY END USERS, 2017-2032 (USD MILLION)
TABLE 246. EUROPEAN UNION IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2017-2032 (USD MILLION)
TABLE 247. BRICS IMMUNOASSAY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 248. BRICS IMMUNOASSAY MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 249. BRICS IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 250. BRICS IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 251. BRICS IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 252. BRICS IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2017-2032 (USD MILLION)
TABLE 253. BRICS IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2017-2032 (USD MILLION)
TABLE 254. BRICS IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2017-2032 (USD MILLION)
TABLE 255. BRICS IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2017-2032 (USD MILLION)
TABLE 256. BRICS IMMUNOASSAY MARKET SIZE, BY END USERS, 2017-2032 (USD MILLION)
TABLE 257. BRICS IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2017-2032 (USD MILLION)
TABLE 258. G7 IMMUNOASSAY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 259. G7 IMMUNOASSAY MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 260. G7 IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 261. G7 IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 262. G7 IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 263. G7 IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2017-2032 (USD MILLION)
TABLE 264. G7 IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2017-2032 (USD MILLION)
TABLE 265. G7 IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2017-2032 (USD MILLION)
TABLE 266. G7 IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2017-2032 (USD MILLION)
TABLE 267. G7 IMMUNOASSAY MARKET SIZE, BY END USERS, 2017-2032 (USD MILLION)
TABLE 268. G7 IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2017-2032 (USD MILLION)
TABLE 269. NATO IMMUNOASSAY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 270. NATO IMMUNOASSAY MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 271. NATO IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 272. NATO IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 273. NATO IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 274. NATO IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2017-2032 (USD MILLION)
TABLE 275. NATO IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2017-2032 (USD MILLION)
TABLE 276. NATO IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2017-2032 (USD MILLION)
TABLE 277. NATO IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2017-2032 (USD MILLION)
TABLE 278. NATO IMMUNOASSAY MARKET SIZE, BY END USERS, 2017-2032 (USD MILLION)
TABLE 279. NATO IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2017-2032 (USD MILLION)
TABLE 280. GLOBAL IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 281. UNITED STATES IMMUNOASSAY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 282. UNITED STATES IMMUNOASSAY MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 283. UNITED STATES IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 284. UNITED STATES IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 285. UNITED STATES IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 286. UNITED STATES IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2017-2032 (USD MILLION)
TABLE 287. UNITED STATES IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2017-2032 (USD MILLION)
TABLE 288. UNITED STATES IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2017-2032 (USD MILLION)
TABLE 289. UNITED STATES IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2017-2032 (USD MILLION)
TABLE 290. UNITED STATES IMMUNOASSAY MARKET SIZE, BY END USERS, 2017-2032 (USD MILLION)
TABLE 291. UNITED STATES IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2017-2032 (USD MILLION)
TABLE 292. GERMANY IMMUNOASSAY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 293. GERMANY IMMUNOASSAY MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 294. GERMANY IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 295. GERMANY IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 296. GERMANY IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 297. GERMANY IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2017-2032 (USD MILLION)
TABLE 298. GERMANY IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2017-2032 (USD MILLION)
TABLE 299. GERMANY IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2017-2032 (USD MILLION)
TABLE 300. GERMANY IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2017-2032 (USD MILLION)
TABLE 301. GERMANY IMMUNOASSAY MARKET SIZE, BY END USERS, 2017-2032 (USD MILLION)
TABLE 302. GERMANY IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2017-2032 (USD MILLION)
TABLE 303. CHINA IMMUNOASSAY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 304. CHINA IMMUNOASSAY MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 305. CHINA IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 306. CHINA IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 307. CHINA IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 308. CHINA IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2017-2032 (USD MILLION)
TABLE 309. CHINA IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2017-2032 (USD MILLION)
TABLE 310. CHINA IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2017-2032 (USD MILLION)
TABLE 311. CHINA IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2017-2032 (USD MILLION)
TABLE 312. CHINA IMMUNOASSAY MARKET SIZE, BY END USERS, 2017-2032 (USD MILLION)
TABLE 313. CHINA IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2017-2032 (USD MILLION)
TABLE 314. UNITED KINGDOM IMMUNOASSAY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 315. UNITED KINGDOM IMMUNOASSAY MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 316. UNITED KINGDOM IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 317. UNITED KINGDOM IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 318. UNITED KINGDOM IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 319. UNITED KINGDOM IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2017-2032 (USD MILLION)
TABLE 320. UNITED KINGDOM IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2017-2032 (USD MILLION)
TABLE 321. UNITED KINGDOM IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2017-2032 (USD MILLION)
TABLE 322. UNITED KINGDOM IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2017-2032 (USD MILLION)
TABLE 323. UNITED KINGDOM IMMUNOASSAY MARKET SIZE, BY END USERS, 2017-2032 (USD MILLION)
TABLE 324. UNITED KINGDOM IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2017-2032 (USD MILLION)
TABLE 325. INDIA IMMUNOASSAY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 326. INDIA IMMUNOASSAY MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 327. INDIA IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 328. INDIA IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 329. INDIA IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 330. INDIA IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2017-2032 (USD MILLION)
TABLE 331. INDIA IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2017-2032 (USD MILLION)
TABLE 332. INDIA IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2017-2032 (USD MILLION)
TABLE 333. INDIA IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2017-2032 (USD MILLION)
TABLE 334. INDIA IMMUNOASSAY MARKET SIZE, BY END USERS, 2017-2032 (USD MILLION)
TABLE 335. INDIA IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2017-2032 (USD MILLION)
TABLE 336. JAPAN IMMUNOASSAY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 337. JAPAN IMMUNOASSAY MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 338. JAPAN IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 339. JAPAN IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 340. JAPAN IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 341. JAPAN IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2017-2032 (USD MILLION)
TABLE 342. JAPAN IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2017-2032 (USD MILLION)
TABLE 343. JAPAN IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2017-2032 (USD MILLION)
TABLE 344. JAPAN IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2017-2032 (USD MILLION)
TABLE 345. JAPAN IMMUNOASSAY MARKET SIZE, BY END USERS, 2017-2032 (USD MILLION)
TABLE 346. JAPAN IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2017-2032 (USD MILLION)
TABLE 347. RUSSIA IMMUNOASSAY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 348. RUSSIA IMMUNOASSAY MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 349. RUSSIA IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 350. RUSSIA IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 351. RUSSIA IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 352. RUSSIA IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2017-2032 (USD MILLION)
TABLE 353. RUSSIA IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2017-2032 (USD MILLION)
TABLE 354. RUSSIA IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2017-2032 (USD MILLION)
TABLE 355. RUSSIA IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2017-2032 (USD MILLION)
TABLE 356. RUSSIA IMMUNOASSAY MARKET SIZE, BY END USERS, 2017-2032 (USD MILLION)
TABLE 357. RUSSIA IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2017-2032 (USD MILLION)
TABLE 358. BRAZIL IMMUNOASSAY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 359. BRAZIL IMMUNOASSAY MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 360. BRAZIL IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 361. BRAZIL IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 362. BRAZIL IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 363. BRAZIL IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2017-2032 (USD MILLION)
TABLE 364. BRAZIL IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2017-2032 (USD MILLION)
TABLE 365. BRAZIL IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2017-2032 (USD MILLION)
TABLE 366. BRAZIL IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2017-2032 (USD MILLION)
TABLE 367. BRAZIL IMMUNOASSAY MARKET SIZE, BY END USERS, 2017-2032 (USD MILLION)
TABLE 368. BRAZIL IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2017-2032 (USD MILLION)
TABLE 369. CANADA IMMUNOASSAY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 370. CANADA IMMUNOASSAY MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 371. CANADA IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 372. CANADA IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 373. CANADA IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 374. CANADA IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2017-2032 (USD MILLION)
TABLE 375. CANADA IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2017-2032 (USD MILLION)
TABLE 376. CANADA IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2017-2032 (USD MILLION)
TABLE 377. CANADA IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2017-2032 (USD MILLION)
TABLE 378. CANADA IMMUNOASSAY MARKET SIZE, BY END USERS, 2017-2032 (USD MILLION)
TABLE 379. CANADA IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2017-2032 (USD MILLION)
TABLE 380. ITALY IMMUNOASSAY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 381. ITALY IMMUNOASSAY MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 382. ITALY IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 383. ITALY IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 384. ITALY IMMUNOASSAY MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 385. ITALY IMMUNOASSAY MARKET SIZE, BY SAMPLE TYPES, 2017-2032 (USD MILLION)
TABLE 386. ITALY IMMUNOASSAY MARKET SIZE, BY DETECTION MODES, 2017-2032 (USD MILLION)
TABLE 387. ITALY IMMUNOASSAY MARKET SIZE, BY APPLICATION AREAS, 2017-2032 (USD MILLION)
TABLE 388. ITALY IMMUNOASSAY MARKET SIZE, BY TOXICOLOGY, 2017-2032 (USD MILLION)
TABLE 389. ITALY IMMUNOASSAY MARKET SIZE, BY END USERS, 2017-2032 (USD MILLION)
TABLE 390. ITALY IMMUNOASSAY MARKET SIZE, BY DEPLOYMENT TYPES, 2017-2032 (USD MILLION)
TABLE 391. MEXICO IMMUNOASSAY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 392. MEXICO IMMUNOASSAY MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 393. MEXICO IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 394. MEXICO IMMUNOASSAY MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 395. MEX

Companies Mentioned

  • Abbott Laboratories
  • Agilent Technologies Inc.
  • ANP Technologies, Inc.
  • Autobio Diagnostics Co., Ltd.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • bioMérieux S.A.
  • Biosurfit SA
  • Boditech Med Inc.
  • Danaher Corporation
  • Diasorin S.p.A.
  • Dynex Technologies, Inc.
  • Epitope Diagnostics Inc.
  • F. Hoffmann-La Roche Ltd.
  • Fapon Biotech Inc.
  • H.U. Group Holdings Inc.
  • J. Mitra & Co. Pvt. Ltd.
  • Kamiya Biomedical Company
  • Merck KGaA
  • MiCo BioMed, Inc.
  • NanoEntek
  • Nanōmix, Inc.
  • OPKO Health, Inc.
  • Promega Corporation
  • QIAGEN N.V.
  • Quanterix Corporation
  • Randox Laboratories Ltd.
  • Shenzhen Micropoint Biotechnologies Co., Ltd.
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Siemens Healthineers AG
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.
  • Tosoh Corporation
  • WAK-Chemie Medical GmbH
  • Zoetis Inc.
  • Zybio Inc.

Table Information

Report AttributeDetails
No. of Pages197
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 32.61 Billion
Forecasted Market Value ( USD ) by 2032 $ 49.98 Billion
Compound Annual Growth Rate7.3%
Regions CoveredGlobal
No. of Companies Mentioned37

Related Topics

Related Reports

Chemiluminescence Immunoassay Analyzers Market - Global Forecast 2026-2032 - Product Image

Chemiluminescence Immunoassay Analyzers Market - Global Forecast 2026-2032

  • Report
  • 196 Pages
  • Global
From
Automatic Chemiluminescence Immunoassay Analyzer Market - Global Forecast 2026-2032 - Product Image

Automatic Chemiluminescence Immunoassay Analyzer Market - Global Forecast 2026-2032

  • Report
  • 198 Pages
  • Global
From
Multiplex Detection Immunoassays - Global Strategic Business Report - Product Image

Multiplex Detection Immunoassays - Global Strategic Business Report

  • Report
  • 257 Pages
  • Global
From
Chemiluminescence Immunoassay Analyzers - Global Strategic Business Report - Product Image

Chemiluminescence Immunoassay Analyzers - Global Strategic Business Report

  • Report
  • 285 Pages
  • Global
From
Chemiluminescence Immunoassay Market by Product, Technology, Sample Type, Application, End User - Global Forecast to 2031 - Product Image

Chemiluminescence Immunoassay Market by Product, Technology, Sample Type, Application, End User - Global Forecast to 2031

  • Report
  • 383 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.